W Andrew Yeudall Selected Research

W Andrew Yeudall Research Topics

Disease

20	Neoplasms (Cancer) 12/2021 - 06/2002
8	Squamous Cell Carcinoma of Head and Neck 01/2020 - 06/2002
7	Head and Neck Neoplasms (Head and Neck Cancer) 09/2019 - 03/2007
5	Carcinogenesis 05/2013 - 03/2007
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2010 - 08/2005
3	Neoplasm Metastasis (Metastasis) 02/2012 - 09/2008
3	Lymphatic Metastasis 04/2006 - 08/2005
2	Lung Neoplasms (Lung Cancer) 03/2016 - 07/2012
2	Inflammation (Inflammations) 01/2015 - 10/2013
1	Brain Neoplasms (Brain Tumor) 12/2021
1	Glioblastoma (Glioblastoma Multiforme) 12/2021
1	Wounds and Injuries (Trauma) 01/2020
1	Mouth Neoplasms (Oral Cancer) 01/2015
1	Infections 01/2015
1	Periodontal Diseases (Periodontal Disease) 01/2015
1	Melanoma (Melanoma, Malignant) 10/2013
1	Periodontitis 10/2013
1	Chronic Periodontitis 10/2013
1	Hypoxia (Hypoxemia) 02/2010
1	Breast Neoplasms (Breast Cancer) 10/2007
1	Polyploidy 10/2007
1	Esophageal Neoplasms (Esophageal Cancer) 06/2005
1	Osteosarcoma (Osteogenic Sarcoma) 03/2004

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 05/2013 - 06/2002
6	Biological ProductsIBA 01/2020 - 08/2005
6	Epidermal Growth Factor (EGF)IBA 02/2019 - 08/2005
6	ChemokinesIBA 01/2015 - 04/2006
4	Dendrimers (Dendrons)IBA 02/2019 - 09/2010
4	ErbB Receptors (EGF Receptor)IBA 03/2016 - 03/2007
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2013 - 03/2006
4	Transforming Growth Factor beta (TGF-beta)IBA 09/2008 - 06/2005
3	Poly(amidoamine)IBA 02/2019 - 11/2016
3	Small Interfering RNA (siRNA)IBA 01/2017 - 04/2010
3	Pharmaceutical PreparationsIBA 10/2013 - 02/2010
3	RNA (Ribonucleic Acid)IBA 07/2012 - 06/2002
2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2017 - 11/2016
2	Nucleic AcidsIBA 10/2013 - 09/2010
2	CytokinesIBA 05/2013 - 03/2007
2	CXC ChemokinesIBA 02/2012 - 04/2006
2	Oncogene Proteins (Oncogene Protein)IBA 06/2005 - 03/2004
1	P-SelectinIBA 12/2021
1	InterleukinsIBA 12/2021
1	Immunologic Factors (Immunomodulators)IBA 12/2021
1	Therapeutic UsesIBA 12/2021
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 12/2021
1	CannabidiolIBA 12/2021
1	ApelinIBA 12/2021
1	Tyrosine (L-Tyrosine)FDA Link 01/2020
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2020
1	CarcinogensIBA 09/2019
1	PAMAM StarburstIBA 01/2017
1	SolutionsIBA 01/2017
1	Green Fluorescent ProteinsIBA 01/2017
1	ChromatinIBA 03/2016
1	Peptides (Polypeptides)IBA 01/2015
1	DNA (Deoxyribonucleic Acid)IBA 10/2013
1	Bacterial DNAIBA 10/2013
1	LigandsIBA 10/2013
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2013
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 10/2013
1	Silk FDA Link 10/2013
1	Interferon Regulatory FactorsIBA 10/2013
1	Toll-Like Receptor 9IBA 10/2013
1	Transforming Growth Factors (Transforming Growth Factor)IBA 05/2013
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 07/2012
1	glycyl-glycyl-glycine (triglycine)IBA 09/2010
1	Vascular Endothelial Growth Factor CIBA 04/2010
1	Oxygen (Dioxygen)IBA 02/2010
1	Interleukin-8 (Interleukin 8)IBA 10/2008
1	Keratins (Keratin)IBA 09/2008
1	VimentinIBA 09/2008
1	Caspase 3 (Caspase-3)IBA 10/2007
1	PyrrolesIBA 10/2007
1	PoisonsIBA 10/2007
1	3,5- dibromo- 4- (3,4- dimethoxyphenyl)- 1H- pyrrole- 2- carboxylic acid ethyl esterIBA 10/2007
1	AntibodiesIBA 09/2007
1	TOR Serine-Threonine KinasesIBA 09/2007
1	Conditioned Culture MediaIBA 04/2006
1	Complementary DNA (cDNA)IBA 03/2006
1	Cyclin AIBA 03/2004

Therapy/Procedure

8	Therapeutics 12/2021 - 09/2007
2	Drug Therapy (Chemotherapy) 12/2021 - 02/2010
1	Radiotherapy 12/2021
1	Precision Medicine 09/2019
1	Transplantation 08/2005